BNP Paribas Financial Markets
PCVX icon

BNP Paribas Financial Markets’s Vaxcyte PCVX Stock Holding History

BNP Paribas Financial Markets’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1M Buy
465,477
+240,959
+107% +$13.1M 0.01% 1094
2026
Q1 		$13M Buy
224,518
+173,756
+342% +$9.43M 0.01% 1422
2025
Q4 		$2.34M Sell
50,762
-206,905
-80% -$9.25M ﹤0.01% 2523
2025
Q3 		$9.28M Buy
257,667
+118,543
+85% +$3.93M 0.01% 1588
2025
Q2 		$4.52M Buy
139,124
+88,692
+176% +$2.91M ﹤0.01% 1921
2025
Q1 		$1.9M Sell
50,432
-40,833
-45% -$3.26M ﹤0.01% 2396
2024
Q4 		$7.47M Buy
+91,265
New +$9.06M ﹤0.01% 1539

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BNP Paribas Financial Markets's PCVX Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Vaxcyte (PCVX) stake by 107% in Q2 2026, buying an estimated $13.1M and bringing the position to 465,477 shares worth $27.1M. The position accounts for 0.01% of the portfolio, ranked #1094.

BNP Paribas Financial Markets first reported a position in PCVX in Q4 2024 and has held it in 7 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • BNP Paribas Financial Markets held 465,477 shares of Vaxcyte worth $27.1M as of Q2 2026.
  • BNP Paribas Financial Markets bought 240,959 Vaxcyte shares in Q2 2026, an estimated $13.1M.
  • Vaxcyte made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1094 holding.
  • BNP Paribas Financial Markets first reported a position in Vaxcyte in Q4 2024 and has held it in 7 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.